SPL 3.09% 9.4¢ starpharma holdings limited

Ann: Shareholder Newsletter, page-36

  1. 48 Posts.
    I'm a long term holder ~11 years . Became interested in drug delivery technology over 10 years ago as I could see a lot of big pharma patents were running out. Being able to extend the life drug with new delivery technology and collaboration/buy out, I thought, was a strategy big pharma would use.

    I been quite impressed with the update and interviews. I increased my holdings by ~50% yesterday.

    Viraleze looks to be a solid product. Not only for SARS-CoV-2, but the potentially multiple strains of influenza and RSV (and maybe other resp viruses). As the lockdowns were lifted our Emergency Departments were inundated with RSV paediatric presentations.

    I see the recommended use of Viraleze is for >12yo. If safety was verified for paediatric use it would be a game changer (i can't see why it wouldn't be safe). We have no preventative measures apart from good hygiene practices. A few good sprays as a drop my children off to day care. I'd be using it day if my kids had a cold. Imagine reduced sick days/increased productivity of a work force.

    I don't wont to understate the importance of prevention of Covid but this could be useful on so many levels



 
watchlist Created with Sketch. Add SPL (ASX) to my watchlist
(20min delay)
Last
9.4¢
Change
-0.003(3.09%)
Mkt cap ! $38.73M
Open High Low Value Volume
10.0¢ 10.0¢ 9.3¢ $57.87K 599.4K

Buyers (Bids)

No. Vol. Price($)
1 49999 9.4¢
 

Sellers (Offers)

Price($) Vol. No.
9.5¢ 85000 2
View Market Depth
Last trade - 16.10pm 17/06/2024 (20 minute delay) ?
Last
9.4¢
  Change
-0.003 ( 4.08 %)
Open High Low Volume
9.6¢ 9.9¢ 9.4¢ 30537
Last updated 15.34pm 17/06/2024 ?
SPL (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.